ClariVest Asset Management’s Immunogen Inc IMGN Stock Holding History

ClariVest Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-20,161	Closed	-$598K	–	928
2023 Q4	$598K	Sell	20,161 -34,230	-63%	-$682K	0.03%	346
2023 Q3	$863K	Buy	54,391 +23,661	+77%	+$393K	0.05%	263
2023 Q2	$580K	Sell	30,730 -86,169	-74%	-$1.02M	0.03%	332
2023 Q1	$449K	Sell	116,899 -101	-0.1%	-$430	0.02%	393
2022 Q4	$581K	Sell	117,000 -1,800	-2%	-$9.76K	0.03%	365
2022 Q3	$568K	Buy	+118,800	New	+$626K	0.03%	350
2022 Q1	–	Sell	-679	Closed	-$5K	–	795
2021 Q4	$5K	Buy	+679	New	+$4.22K	﹤0.01%	580
2014 Q4	–	Sell	-15,000	Closed	-$159K	–	625
2014 Q3	$159K	Buy	+15,000	New	+$170K	0.01%	395

Other funds holding IMGN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

ClariVest Asset Management's IMGN Position: Q1 2024 in Review

ClariVest Asset Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 20,161 shares — an estimated $598K sold.

ClariVest Asset Management first reported a position in IMGN in Q3 2014 and held it in 8 quarters. The position peaked at $863K in Q3 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

ClariVest Asset Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
ClariVest Asset Management sold 20,161 Immunogen Inc shares in Q1 2024, an estimated $598K.
ClariVest Asset Management first reported a position in Immunogen Inc in Q3 2014 and held it in 8 quarters.
ClariVest Asset Management's Immunogen Inc position peaked at $863K in Q3 2023.
3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on ClariVest Asset Management's 13F filing for Q1 2024, filed 7 May 2024.